Mortality of critically ill patients with severe influenza starting four years after the 2009 pandemic

References

• Vaughan VC. An explosive epidemic of influenzal disease at the fort Oglehorpe. J Lab Clin Med. 1918;3:560–568.
   Google Scholar
• Smith W, Andrewes C, Laidlaw P. A virus obtained from Influenza patients. The Lancet. 1933;2:66–68.
   Google Scholar
• Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–1895.
   PubMed Web of Science ®Google Scholar
• Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economics assessment of conventional ventilator support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet. 2009;374(9698):1351–1363.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–2533.
   PubMed Web of Science ®Google Scholar
• Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107.
   PubMed Web of Science ®Google Scholar
• Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Díaz E, Vidaur L, et al. Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit Care. 2011;15(6):R286.
   PubMed Web of Science ®Google Scholar
• Pérez-Carrasco M, Lagunes L, Antón A, et al. Influenza infection in the intensive care unit: four years after the 2009 pandemic. Enferm Infecc Microbiol Clin. 2016;34(3):177–183.
   PubMed Web of Science ®Google Scholar
• Gil Cuesta J, Aavitsland P, Englund H, et al. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience. Euro Surveill. 2016;21(16).
   PubMedGoogle Scholar
• Vandroux D, Brottet E, Ursulet L, et al. New patterns of A(H1N1)pdm09 influenza in the Southern Hemisphere. Intensive Care Med. 2014;40(1):131–132.
   PubMed Web of Science ®Google Scholar
• Taglioni F, Cartoux M, Dellagi K, et al. The influenza A (H1N1) pandemic in Reunion Island: knowledge, perceived risk and precautionary behaviour. BMC Infect Dis. 2013;13(1):34.
   PubMed Web of Science ®Google Scholar
• Parcevaux M, Antok E, Boisson V, et al. Acute respiratory distress due to Influenza A (H1N1) S-OIV and extracorporeal oxygenation: the benefit of a multidisciplinary care network. Ann Fr Anesth Reanim. 2010;29(2):145–148.
   PubMedGoogle Scholar
• Ylipalosaari P, Ala-Kokko TI, Laurila J, et al. ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis. BMC Infect Dis. 2017;17(1):728.
   PubMedGoogle Scholar
• Gaüzère BA, Bussienne F, Bouchet B, et al. Severe cases of A(H1N1)v2009 infection in Réunion Island in 2009 and 2010. Bull Soc Pathol Exot. 2011;104(2):97–104.
   PubMedGoogle Scholar
• Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA. 1919;72(9):617–626.
   Google Scholar
• Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16(5):e321–31.
   PubMed Web of Science ®Google Scholar
• Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487–1498.
   PubMed Web of Science ®Google Scholar
• Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139(3):555–562.
   PubMed Web of Science ®Google Scholar
• Grimaldi D, Llitjos JF, Pène F. Post-infectious immune suppression: a new paradigm of severe infections. Med Mal Infect. 2014;44(10):455–463.
   PubMed Web of Science ®Google Scholar
• McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12(4):252–262.
   PubMed Web of Science ®Google Scholar
• Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009;119(7):1910–1920.
   PubMed Web of Science ®Google Scholar
• Vanhecke C, Girerd R, Dujardin M, et al. Retrospective study of pneumonia due to panton-valentine leukocidin-producing Staphylococcus aureus at Reunion Island between December, 2014 and December, 2017, in Emergency Department. Med Mal Inf. 2019.
   PubMedGoogle Scholar
• Fedson DS. Clinician-initiated research on treating the host response to pandemic influenza. Hum Vac Immunotherapeut. 2017;14(3):790–795.
   PubMed Web of Science ®Google Scholar
• Vandermeer ML, Thomas AR, Kamimoto L, et al. Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis. 2012;205(1):13–19.
   PubMed Web of Science ®Google Scholar
• Mortensen EM, Nakashima B, Cornell J, et al. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis. 2012;55(11):1466–1473.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA. 2017;114(47):12578–12583.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Robertson CA, et al. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty. Vaccine. 2015;33(36):4565–4571.
   PubMed Web of Science ®Google Scholar